CME Group (NASDAQ:CME) Director Sells 400 Shares of Company Stock

CME Group Inc. (NASDAQ:CME) Director Martin Gepsman sold 400 shares of the stock in a transaction dated Thursday, October 22nd. The shares were sold at an average price of $302.50, for a total transaction of $121,000.00. Following the completion of the sale, the director owned 25,244 shares of the company’s stock, valued at approximately $7,636,310. This trade represents a 1.56% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.

CME Group Stock Performance

Shares of CME Group stock traded up $10.19 during mid-day trading on Thursday, hitting $305.98. 2,294,356 shares of the stock were exchanged, compared to its average volume of 2,520,842. CME Group Inc. has a 12 month low of $218.31 and a 12 month high of $329.16. The company has a 50-day simple moving average of $276.11 and a 200 day simple moving average of $270.49. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The company has a market capitalization of $110.02 billion, a P/E ratio of 25.95, a P/E/G ratio of 3.80 and a beta of 0.24.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, October 21st. The financial services provider reported $3.02 earnings per share for the quarter, topping analysts’ consensus estimates of $2.99 by $0.03. The firm had revenue of $1.74 billion for the quarter, compared to the consensus estimate of $1.71 billion. CME Group had a return on equity of 15.60% and a net margin of 63.30%. The company’s revenue was up 10.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.68 EPS. Sell-side analysts anticipate that CME Group Inc. will post 12.31 earnings per share for the current fiscal year.

CME Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, September 25th. Investors of record on Wednesday, September 9th were issued a $1.30 dividend. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date of this dividend was Wednesday, September 9th. CME Group’s payout ratio is 44.11%.

Key Stories Impacting CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: JPMorgan upgraded CME to Overweight and set a $367 price target, implying substantial upside from the current level. The upgrade provides a strong boost to investor sentiment. JPMorgan analyst rating
• Positive Sentiment: Third-quarter results exceeded expectations: CME reported $1.74 billion in revenue, up 10.6% year over year and above the approximately $1.71 billion consensus estimate. Adjusted earnings of $3.02 per share also topped forecasts near $2.99 and increased from $2.68 a year earlier. CME Group third-quarter earnings release
• Positive Sentiment: Record volumes and market-data revenue point to durable operating momentum. Average daily volume reached 29.4 million contracts, including 9 million from outside the United States, while market-data revenue rose 20% to a record $243 million. CME also returned nearly $1 billion to shareholders through dividends and repurchases. CME Group long-term investor takeaways
• Positive Sentiment: Growth initiatives could broaden CME’s revenue base. The company outlined a December 7 launch for CME Securities Clearing and continued expansion in cryptocurrency products, including a first UNI futures block trade and planned tradable token-index products. CME Securities Clearing and volume update
• Neutral Sentiment: UBS raised its price target to $310 from $270 but maintained a Neutral rating. The revised target suggests limited near-term upside, indicating that UBS views the strong results as largely reflected in CME’s valuation. UBS CME analyst rating
• Negative Sentiment: Some investors remained concerned about expenses. Initial coverage noted that operating costs disappointed despite the earnings beat, limiting the immediate upside reaction and leaving questions about margin sustainability. CME earnings and expense coverage

Institutional Investors Weigh In On CME Group

Institutional investors have recently made changes to their positions in the stock. Bridgewater Advisors Inc. bought a new stake in CME Group in the 2nd quarter worth approximately $612,000. The Manufacturers Life Insurance Company bought a new position in shares of CME Group during the 2nd quarter valued at $53,671,000. Focus Financial Network Inc. bought a new position in shares of CME Group during the 3rd quarter valued at $1,513,000. Haverford Trust Co purchased a new position in shares of CME Group in the 2nd quarter worth $13,818,000. Finally, Bowie Capital Management LLC purchased a new position in shares of CME Group in the 2nd quarter worth $22,991,000. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on CME shares. Bank of America raised their target price on CME Group from $226.00 to $230.00 and gave the stock an “underperform” rating in a research report on Thursday, July 23rd. Morgan Stanley upped their price target on CME Group from $337.00 to $359.00 and gave the company an “overweight” rating in a research report on Thursday. The Goldman Sachs Group dropped their price target on CME Group from $267.00 to $245.00 and set a “sell” rating on the stock in a research report on Tuesday, June 30th. CLSA set a $367.00 price target on CME Group in a research note on Thursday. Finally, JPMorgan Chase & Co. raised shares of CME Group from an “underweight” rating to an “overweight” rating and set a $367.00 price objective on the stock in a report on Thursday. Ten analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, CME Group has a consensus rating of “Hold” and a consensus price target of $313.29.

CME Group Company Profile

CME Group Inc operates global derivatives marketplaces that provide trading, clearing and settlement services for futures and options contracts. Its products cover major asset classes, including interest rates, equity indexes, foreign currencies, agricultural commodities, energy and metals. The company also provides market data, benchmark information and related services used by financial institutions, corporations, producers, investors and other market participants.

CME Group’s exchange portfolio includes CME, the Chicago Board of Trade, the New York Mercantile Exchange and COMEX.